5 Best Stocks To Buy For A Stock Market Game

In this article, we will be taking a look at the 5 best stocks to buy for a stock market game. To see more of these stocks, you can go directly to see the 10 Best Stocks To Buy For A Stock Market Game.

5. Geron Corporation (NASDAQ:GERN)

One-Year Return as of April 25: 59.81%

Number of Hedge Fund Holders: 18

Geron Corporation (NASDAQ:GERN) is a biopharmaceutical company. It is based in Foster City, California.

On March 27, analysts at Goldman Sachs initiated coverage of Geron Corporation (NASDAQ:GERN) shares with a Neutral rating.

Analysts on Wall Street placed an average price target of $4.67 on Geron Corporation (NASDAQ:GERN) shares, which were trading at $2.42 on April 25. This gives the stock an upside potential of 92.98%.

There were 18 hedge funds long Geron Corporation (NASDAQ:GERN) in the fourth quarter. Their total stake value was $154 million.

4. Overseas Shipholding Group, Inc. (NYSE:OSG)

One-Year Return as of April 25: 71.15%

Number of Hedge Fund Holders: 20

Overseas Shipholding Group, Inc. (NYSE:OSG) is an oil and gas storage and transportation company. It is based in Tampa, Florida.

In the fourth quarter, Overseas Shipholding Group, Inc. (NYSE:OSG) generated shipping revenues of $467 million, compared to $359 million in 2021. The stock’s price has gained 71.15% over the past year, as of April 25.

Overseas Shipholding Group, Inc. (NYSE:OSG) was found among the 13F holdings of 20 hedge funds in the fourth quarter, with a total stake value of $40.2 million.

3. Compass Therapeutics Inc. (NASDAQ:CMPX)

One-Year Return as of April 25: 79.87%

Number of Hedge Fund Holders: 20

Compass Therapeutics Inc. (NASDAQ:CMPX) is a biotechnology company focused on oncology. It is based in Boston, Massachusetts.

Robert Driscoll, an analyst at Wedbush, holds an Outperform rating on Compass Therapeutics Inc. (NASDAQ:CMPX) shares as of April 20.

The average price target placed on shares of Compass Therapeutics Inc. (NASDAQ:CMPX) by Wall Street analysts is $9.2, while the shares were trading at $2.67 on April 25. This gives them an upside potential of 243.93%.

A total of 20 hedge funds were long Compass Therapeutics Inc. (NASDAQ:CMPX) in the fourth quarter, with a total stake value of $224 million.

2. ADMA Biologics, Inc. (NASDAQ:ADMA)

One-Year Return as of April 25: 67.77%

Number of Hedge Fund Holders: 21

ADMA Biologics, Inc. (NASDAQ:ADMA) is another biotechnology company on our list. It is based in Ramsey, New Jersey.

ADMA Biologics, Inc. (NASDAQ:ADMA) generated revenues of $50 million in the fourth quarter, representing an increase of 90% year-over-year. The company’s total asset value by the end of 2022 was about $348 million.

Our hedge fund data shows 21 funds long ADMA Biologics, Inc. (NASDAQ:ADMA) in the fourth quarter. Their total stake value was $212 million.

1. WAVE Life Sciences Ltd. (NASDAQ:WVE)

One-Year Return as of April 25: 87.13%

Number of Hedge Fund Holders: 23

WAVE Life Sciences Ltd. (NASDAQ:WVE) is a pharmaceutical company. It is based in Singapore.

Mizuho analysts hold a Buy rating on WAVE Life Sciences Ltd. (NASDAQ:WVE) shares as of April 14.

Analysts on Wall Street have placed an average price target of $8.25 on WAVE Life Sciences Ltd. (NASDAQ:WVE) shares, which were trading at $3.84 on April 25. This gives the stock an upside potential of 114.84%.

WAVE Life Sciences Ltd. (NASDAQ:WVE) had 23 hedge funds long its stock in the fourth quarter, with a total stake value of $339 million.

See also 12 Cheapest Penny Stocks According to Analysts and 10 Penny Stocks with Insider Buying.